JB Capital’s Exact Sciences EXAS Stock Holding History

JB Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-36,076	Closed	-$3.66M	–	266
2025 Q4	$3.66M	Buy	36,076 +4,434	+14%	+$356K	0.15%	71
2025 Q3	$1.73M	Buy	31,642 +9,728	+44%	+$486K	0.07%	118
2025 Q2	$1.16M	Buy	+21,914	New	+$1.11M	0.06%	122

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JB Capital's EXAS Position: Q1 2026 in Review

JB Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 36,076 shares — an estimated $3.66M sold.

JB Capital first reported a position in EXAS in Q2 2025 and held it in 3 quarters. The position peaked at $3.66M in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

JB Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
JB Capital sold 36,076 Exact Sciences shares in Q1 2026, an estimated $3.66M.
JB Capital first reported a position in Exact Sciences in Q2 2025 and held it in 3 quarters.
JB Capital's Exact Sciences position peaked at $3.66M in Q4 2025.
6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on JB Capital's 13F filing for Q1 2026, filed 27 Apr 2026.